1. Home
  2. VET vs BHVN Comparison

VET vs BHVN Comparison

Compare VET & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vermilion Energy Inc.

VET

Vermilion Energy Inc.

HOLD

Current Price

$8.13

Market Cap

1.3B

Sector

Energy

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$10.89

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VET
BHVN
Founded
1994
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
VET
BHVN
Price
$8.13
$10.89
Analyst Decision
Buy
Analyst Count
0
16
Target Price
N/A
$29.79
AVG Volume (30 Days)
1.6M
3.1M
Earning Date
11-05-2025
11-10-2025
Dividend Yield
4.61%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,445,514,003.00
N/A
Revenue This Year
$9.23
N/A
Revenue Next Year
N/A
$2,219.74
P/E Ratio
N/A
N/A
Revenue Growth
30.48
N/A
52 Week Low
$5.14
$7.48
52 Week High
$10.49
$44.28

Technical Indicators

Market Signals
Indicator
VET
BHVN
Relative Strength Index (RSI) 41.72 50.98
Support Level $7.95 $10.69
Resistance Level $9.28 $11.80
Average True Range (ATR) 0.33 0.74
MACD -0.15 0.26
Stochastic Oscillator 12.54 74.08

Price Performance

Historical Comparison
VET
BHVN

About VET Vermilion Energy Inc.

Vermilion Energy Inc is an international oil and gas-producing company. The company engages in full-cycle exploration and production programs that focus on the acquisition, exploration, development, and optimization of producing properties in North America, Europe, and Australia. The majority of Vermilion's revenue is derived from the production and sale of petroleum and natural gas. In each market, the company relies on a host of drilling and well-completion techniques to keep production at attractive levels. Geographically, the company derives majority of its revenue from Canada.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: